Industry

Mayo Clinic again was named to DiversityInc's Top Hospitals and Health Systems ranking. This is the seventh consecutive year that Mayo has been ranked among the top health care organizations for its commitment to diversity, inclusion, and equity.

By Mayo Clinic News Network • May 4, 2018

Illnesses caused by disease-infected ticks, mosquitoes, and fleas have tripled in the U.S. in recent years, according to a new report from the Centers for Disease Control and Prevention. Lyme disease is the most common illness attributed to ticks.

By Mayo Clinic News Network • May 4, 2018

Multiple Mayo Clinic locations have received national recognition for their sustainability efforts through Practice Greenhealth, a national organization dedicated to reducing health care’s impact on the environment. The annual awards recognize health care organizations that have implemented programs to improve environmental performance and continuously work toward higher sustainability goals.

By Mayo Clinic News Network • April 20, 2018

Regional Health has selected Mayo Medical Laboratories as its primary reference laboratory. The agreement provides Regional Health Rapid City Hospital physicians and caregivers with access to Mayo Clinic’s extensive menu of more than 4,000 laboratory tests in every subspecialty of medicine.

By Gina Chiri-Osmond • April 17, 2018

St. Charles Health System in Bend, Oregon, has selected Mayo Medical Laboratories as its primary reference laboratory, giving the health system access to Mayo Clinic’s extensive menu of laboratory tests and clinical expertise.

By Gina Chiri-Osmond • April 6, 2018

Mayo Clinic’s Minnesota campus has been recognized as a 2018 LGBTQ Healthcare Equality Leader, registering a top score of 100 from the Human Rights Campaign Foundation, a civil rights organization, on its 2018 Healthcare Equality Index.

By Mayo Clinic News Network • April 3, 2018

Mayo Laboratory Inquiry (MLI) has been named a Center of Excellence by BenchmarkPortal for the seventh year in a row. MLI was also named a Top Contact Center and took home the top honors in the "Lowest Average Speed of Answer" category.

By Molly Dee • March 27, 2018

There have been concerns in the U.S. recently about the possible harmful side effects from absorbing gadolinium-based contrast agents into the body during some MRI exams. To address some of the anxiety and concerns over this issue, Paul Jannetto, Ph.D., DABCC, FAACC, and Joshua Bornhorst, Ph.D., DABCC, FAACC, Co-Directors of the Mayo Clinic Metals Laboratory and leading experts in this field, have compiled the following list of the most up-to-date information.

By Chris Bahnsen • February 27, 2018

The National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory societies have announced a new collaboration to remove barriers to testing for chronic kidney disease.

By Gina Chiri-Osmond • February 27, 2018

Mayo Clinic and WuXi AppTec Group announced a joint venture to co-develop and deliver clinical diagnostic services in China. The new entity will accelerate the development of novel esoteric tests that both organizations will offer in their respective markets.

By Gina Chiri-Osmond • January 9, 2018

Sparrow Health System has chosen Mayo Medical Laboratories as its primary reference laboratory for advanced laboratory testing, enhancing the availability of complex tests and making test results available more quickly to providers and patients through ISparrow, Sparrow’s electronic medical record.

By Gina Chiri-Osmond • January 5, 2018

Mayo Medical Laboratories and National University Hospital (NUH) in Singapore are now electronically linked via the widely used and secure Health Level 7 interface, enabling NUH to order specialized Mayo laboratory tests and receive patient results in real time.

By Gina Chiri-Osmond • December 5, 2017

sphingotec GmbH, a biotechnology company that develops biomarkers for the detection and management of diseases, has recently signed an agreement with Mayo Clinic to collaborate on the evaluation and use of several biomarkers that may improve the diagnosis of certain disease states, including kidney disease, breast cancer, sepsis, and cardiovascular disease.

By Gina Chiri-Osmond • December 4, 2017